SIGA Announces BARDA Exercise of Procurement Option Valued at $112.5 Million for Oral TPOXX


On 13 September, SIGA announced the exercise of a procurement option under its 75A50118C00019 (19C) contract with Biomedical Advanced Research and Development Authority (BARDA), part of the office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services for the delivery of oral TPOXX® treatment courses valued at approximately $112.5 million to the U.S. government. Product deliveries in connection with the option exercise are targeted for 2021

Read more about this news here.

Related articles

Recent articles